Check if your research matches the topics covered in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Researcher.Life is built on Editage's in-depth understanding of what researchers need during publication and beyond, accumulated over 20 years.
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Sign up now and unlock a detailed chart of Time to publish for this journal
Indexed in the following public directories
Overview | |
Publisher | DOVE MEDICAL PRESS LTD |
Language | English |
Frequency | Continuous publication |
Article Processing Charges | USD 2836 |
Publication Time | 16 |
Editorial Review Process | Anonymous peer review |
General Details | |
Language | English |
Frequency | Continuous publication |
Publication Start Year | 2008 |
Publisher URL | Visit website |
Website URL | Visit website |
Publication Details | |
Editorial Review Detail | |
Information for authors | |
Author instructions | Visit website |
Copyright Details | Visit website |
Deposit Policy | Sherpa/Romeo |
License type | CC BY, CC BY-NC |
OA statement | Visit website |
Upload your Manuscript to get
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
2.8K articles received 31.9K citationssee all
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy has been in operation since 2008 till date.
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy published with a Continuous publication frequency.
In 2023, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy publsihed 373 articles.
For Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, eISSN is 1178-7007 and pISSN is 1178-7007.
Citescore for Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is 3.5.
SNIP score for Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is 0.92.
SJR for Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is Q3.
DOVE MEDICAL PRESS LTD is the publisher of Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.